GUGGENHEIM CAPITAL LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,037,595
-23.4%
20,661
-3.5%
0.01%
-18.2%
Q2 2023$1,353,744
+16.3%
21,420
-17.2%
0.01%
+10.0%
Q1 2023$1,164,206
-31.6%
25,877
-33.4%
0.01%
-33.3%
Q4 2022$1,701,800
-21.4%
38,845
+18.2%
0.02%
-25.0%
Q3 2022$2,166,000
+9.4%
32,870
-16.1%
0.02%
+25.0%
Q2 2022$1,979,000
-19.7%
39,184
+1.6%
0.02%
+6.7%
Q1 2022$2,464,000
-42.3%
38,562
-3.4%
0.02%
-31.8%
Q4 2021$4,274,000
-10.2%
39,900
-13.8%
0.02%
-24.1%
Q3 2021$4,760,000
+17.9%
46,298
+0.8%
0.03%
+20.8%
Q2 2021$4,039,000
+13.4%
45,924
+25.3%
0.02%
+4.3%
Q1 2021$3,563,000
+3.4%
36,643
+19.2%
0.02%
+4.5%
Q4 2020$3,447,000
+280.5%
30,737
+214.3%
0.02%
+214.3%
Q3 2020$906,000
+19.7%
9,778
+0.7%
0.01%
+16.7%
Q2 2020$757,000
-65.9%
9,709
-74.5%
0.01%
-72.7%
Q1 2020$2,223,000
-34.2%
38,022
-9.8%
0.02%
-12.0%
Q4 2019$3,378,000
-8.7%
42,165
-11.1%
0.02%
+4.2%
Q3 2018$3,701,000
+26.1%
47,412
+2.5%
0.02%
+20.0%
Q2 2018$2,936,000
-20.6%
46,262
+14.6%
0.02%
+122.2%
Q1 2018$3,700,000
+35.1%
40,351
+11.0%
0.01%
+50.0%
Q4 2017$2,739,00036,3460.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders